78 related articles for article (PubMed ID: 18460348)
1. Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells.
Mijatovic S; Maksimovic-Ivanic D; Mojic M; Malaponte G; Libra M; Cardile V; Miljkovic D; Harhaji L; Dabideen D; Cheng KF; Bevelacqua Y; Donia M; Garotta G; Al-Abed Y; Stosic-Grujicic S; Nicoletti F
Nitric Oxide; 2008 Sep; 19(2):177-83. PubMed ID: 18460348
[TBL] [Abstract][Full Text] [Related]
2. Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo.
Maksimovic-Ivanic D; Mijatovic S; Harhaji L; Miljkovic D; Dabideen D; Fan Cheng K; Mangano K; Malaponte G; Al-Abed Y; Libra M; Garotta G; Nicoletti F; Stosic-Grujicic S
Mol Cancer Ther; 2008 Mar; 7(3):510-20. PubMed ID: 18347138
[TBL] [Abstract][Full Text] [Related]
3. The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis.
Donia M; Mijatovic S; Maksimovic-Ivanic D; Miljkovic D; Mangano K; Tumino S; Biondi A; Basile F; Al-Abed Y; Stosic-Grujicic S; Nicoletti F
Eur J Pharmacol; 2009 Aug; 615(1-3):228-33. PubMed ID: 19446546
[TBL] [Abstract][Full Text] [Related]
4. Induction of caspase-independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NO.
Mijatovic S; Maksimovic-Ivanic D; Timotijevic G; Miljkovic D; Donia M; Libra M; Coco M; McCubrey J; Al-Abed Y; Korac A; Stosic-Grujicic S; Nicoletti F
Free Radic Biol Med; 2010 Apr; 48(8):1090-9. PubMed ID: 20114073
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of nitric oxide-modified drugs in colon cancer cells.
Mojic M; Mijatovic S; Maksimovic-Ivanic D; Miljkovic D; Stosic-Grujicic S; Stankovic M; Mangano K; Travali S; Donia M; Fagone P; Zocca MB; Al-Abed Y; McCubrey JA; Nicoletti F
Mol Pharmacol; 2012 Oct; 82(4):700-10. PubMed ID: 22798453
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells.
Mijatovic S; Maksimovic-Ivanic D; Mojic M; Timotijevic G; Miljkovic D; Mangano K; Donia M; Di Cataldo A; Al-Abed Y; Cheng KF; Stosic-Grujicic S; Nicoletti F
J Cell Physiol; 2011 Jul; 226(7):1803-12. PubMed ID: 21506111
[TBL] [Abstract][Full Text] [Related]
7. Effects of GIT-27NO, a NO-donating compound, on hepatic ischemia/reperfusion injury.
Mangano K; Lanteri R; Basile MS; Bellavia N; Latino R; Messina D; Fagone P; Colletti G; Nania R; Caltabiano R; Di Marco R; Di Cataldo A
Int J Immunopathol Pharmacol; 2019; 33():2058738419862736. PubMed ID: 31298048
[TBL] [Abstract][Full Text] [Related]
8. Selenocystine induces apoptosis of A375 human melanoma cells by activating ROS-mediated mitochondrial pathway and p53 phosphorylation.
Chen T; Wong YS
Cell Mol Life Sci; 2008 Sep; 65(17):2763-75. PubMed ID: 18661100
[TBL] [Abstract][Full Text] [Related]
9. Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer.
Huerta-Yepez S; Baritaki S; Baay-Guzman G; Hernandez-Luna MA; Hernandez-Cueto A; Vega MI; Bonavida B
Nitric Oxide; 2013 Feb; 29():17-24. PubMed ID: 23246440
[TBL] [Abstract][Full Text] [Related]
10. Phenethyl isothiocyanate triggers apoptosis in human malignant melanoma A375.S2 cells through reactive oxygen species and the mitochondria-dependent pathways.
Huang SH; Hsu MH; Hsu SC; Yang JS; Huang WW; Huang AC; Hsiao YP; Yu CC; Chung JG
Hum Exp Toxicol; 2014 Mar; 33(3):270-83. PubMed ID: 23760257
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1.
Huerta-Yepez S; Vega M; Escoto-Chavez SE; Murdock B; Sakai T; Baritaki S; Bonavida B
Nitric Oxide; 2009 Feb; 20(1):39-52. PubMed ID: 18778787
[TBL] [Abstract][Full Text] [Related]
12. Benzyl isothiocyanate (BITC) induces G2/M phase arrest and apoptosis in human melanoma A375.S2 cells through reactive oxygen species (ROS) and both mitochondria-dependent and death receptor-mediated multiple signaling pathways.
Huang SH; Wu LW; Huang AC; Yu CC; Lien JC; Huang YP; Yang JS; Yang JH; Hsiao YP; Wood WG; Yu CS; Chung JG
J Agric Food Chem; 2012 Jan; 60(2):665-75. PubMed ID: 22148415
[TBL] [Abstract][Full Text] [Related]
13. Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells.
Hung FM; Chen YL; Huang AC; Hsiao YP; Yang JS; Chung MT; Chueh FS; Lu HF; Chung JG
Oncol Rep; 2013 Mar; 29(3):1053-60. PubMed ID: 23314229
[TBL] [Abstract][Full Text] [Related]
14. Sodium ascorbate inhibits growth via the induction of cell cycle arrest and apoptosis in human malignant melanoma A375.S2 cells.
Lin SY; Lai WW; Chou CC; Kuo HM; Li TM; Chung JG; Yang JH
Melanoma Res; 2006 Dec; 16(6):509-19. PubMed ID: 17119452
[TBL] [Abstract][Full Text] [Related]
15. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.
Bush JA; Cheung KJ; Li G
Exp Cell Res; 2001 Dec; 271(2):305-14. PubMed ID: 11716543
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release.
Maragos CM; Wang JM; Hrabie JA; Oppenheim JJ; Keefer LK
Cancer Res; 1993 Feb; 53(3):564-8. PubMed ID: 8425188
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics.
Bonavida B; Garban H
Redox Biol; 2015 Dec; 6():486-494. PubMed ID: 26432660
[TBL] [Abstract][Full Text] [Related]
18. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
19. A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.
Stosic-Grujicic S; Cvetkovic I; Mangano K; Fresta M; Maksimovic-Ivanic D; Harhaji L; Popadic D; Momcilovic M; Miljkovic D; Kim J; Al-Abed Y; Nicoletti F
J Pharmacol Exp Ther; 2007 Mar; 320(3):1038-49. PubMed ID: 17148780
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide donor augments antineoplastic effects of arginine deprivation in human melanoma cells.
Mayevska O; Chen O; Karatsai O; Bobak Y; Barska M; Lyniv L; Pavlyk I; Rzhepetskyy Y; Igumentseva N; Redowicz MJ; Stasyk O
Exp Cell Res; 2017 Jun; 355(2):162-171. PubMed ID: 28390676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
